Latest News and Press Releases
Want to stay updated on the latest news?
-
ARKAY introduces BEYOND SPIRITS and BEYOND WHISKY Plant-Based, a premium alcohol-free whisky alternative.
-
På grund af lokale børslukkedage i underliggende markeder anmodes om suspension af nedenstående andelsklasser. AndelsklasserISINShort nameEmerging Markets Aktier ADK0060516854BAIEMMAAEmerging Market...
-
Vilmorin & Cie announces €300 million long-term financing agreement with the European Investment Bank (EIB). This €300 million loan follows an initial EIB loan of €170 million granted in 2020 and...
-
TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYT1DJ19 Issuer Name ICG PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting...
-
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS NB...
-
UK and US trial sites open; first patient dosed with TGX-007, Trogenix’s proprietary dual-payload AAV gene therapyTGX-007 leverages Trogenix’s precision synthetic super-enhancer platform that...
-
Orphan Drug Designation confers regulatory, financial and strategic advantagesEO2463 has shown potentially disease modifying activity in clinical testing in watch-and-wait iNHL patientsEO2463 has...
-
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN...
-
Bottom line focus yields best Q1 profitability in company history 2026 is the first year in which we fully focus on the Azerion advertising platform after discontinuing our Premium Games segment in...
-
IQIRVO® data expands scientific evidence in fatigue, showing clinically meaningful improvements in patients with moderate-to-severe fatigue at baselineIn the first real-world analysis in patients...